Sylvie Leotin, Founder & CEO
Alternatively described a polymath or a renaissance woman, Sylvie Leotin is an innovator, speaker, and entrepreneur with an uncommonly broad multidisciplinary background. Currently CEO of Equify Health, she founded the company on the heel of her cancer journey to bring innovative ideas and approaches to addressing health disparities.
Sylvie’s polymathic career path crosses industries, disciplines, continents, and cultures. She started her career as a professional ballerina, earning a prestigious gold medal from France’s National Conservatory. She subsequently became a computer scientist and moved to Silicon Valley to be a Visiting Scholar at Stanford Robotics Laboratory. A vacuum for multidisciplinary knowledge, Sylvie has an uncommonly broad professional experience, ranging from engineering to product management, marketing, communication, business development, research, human-centered design, and innovation.
In 2021, Sylvie was awarded a $750,0000 Health Equity Innovation Award from Genentech, in collaboration with Emory University School of Medicine, to develop and pilot a groundbreaking training training (she designed) to reduce systemic health disparities.
Before founding Equify Health, Sylvie was the founder and CEO of Tech Atelier, a strategy consultancy advising innovative companies on product and marketing strategy. She served as interim Vice President of Marketing for a number of startup companies and worked with industry giants, including NASA, Oracle, and Google.
A former HuffPost contributor and influential blogger, Sylvie has been published in numerous media, academic, and literary publications. Her Blog on her cancer experience rose to the top 1% most shared blogs. She is currently writing a much-anticipated book on hre cancer journey.
Sylvie holds an MS in Engineering-Economic Systems from Stanford University and an MS in Computer Science from INSIEE. She studied math, physics, and dance undergraduate. Sylvie has served on the board of the Museum of Performance and Design and the Stanford Cancer Center Patient and Family Advisory Council.